Form 4: LeMaitre Vascular CEO Executes Internal Share Transfer

Chairman and CEO George W. LeMaitre transferred 11,974 shares of common stock to an irrevocable family trust.

Summary

• George W. LeMaitre, Chairman and CEO of LeMaitre Vascular, Inc., transferred 11,974 shares of common stock from his direct holdings to the LeMaitre Irrevocable Life Insurance Trust of 2025.
• The transaction was executed on June 4, 2026, at a price of $0, representing a gift transfer.
• Following the transaction, the CEO holds 1,418,045 shares directly and 45,374 shares indirectly through the trust.
• The filing also reports the accrual of 71.2736 dividend equivalent rights associated with various restricted stock unit and performance share unit awards.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a change in the form of ownership rather than a change in the total economic interest or a market-facing transaction.

Positives

• The transaction reflects long-term estate planning rather than a divestment of equity.
• The CEO maintains a significant direct ownership stake of 1,418,045 shares.

Negatives

• None identified; this is a routine internal transfer of beneficial ownership.

Risks

• None identified; this is a routine internal transfer of beneficial ownership.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that internal transfers of shares to family trusts are standard practice for executives managing estate planning and do not typically signal a change in confidence regarding company performance.

Comparison to Industry Standards

• The transaction is consistent with standard executive compensation and estate planning practices observed in the medical device sector.

Related Party Transactions

• Transfer of 11,974 shares to the LeMaitre Irrevocable Life Insurance Trust of 2025.

Stakeholder Impact

• Minimal impact on shareholders as the CEO's total economic interest in the company remains unchanged.

Next Steps

• No future actions or milestones mentioned.

Key Dates

Keywords

LeMaitre Vascular, LMAT, Insider Trading, Form 4, George LeMaitre, Beneficial Ownership